ATE261301T1 - Arzneizubereitungen enthaltend nicht-steroidale entzündungshemmende arzneimittel - Google Patents
Arzneizubereitungen enthaltend nicht-steroidale entzündungshemmende arzneimittelInfo
- Publication number
- ATE261301T1 ATE261301T1 AT95936694T AT95936694T ATE261301T1 AT E261301 T1 ATE261301 T1 AT E261301T1 AT 95936694 T AT95936694 T AT 95936694T AT 95936694 T AT95936694 T AT 95936694T AT E261301 T1 ATE261301 T1 AT E261301T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- steroidal anti
- date
- sec
- inflammatory drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ZA949055 | 1994-11-15 | ||
| PCT/GB1995/002679 WO1996014839A1 (en) | 1994-11-15 | 1995-11-14 | Pharmaceutical composition comprising non-steroidal anti-inflammatory drugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE261301T1 true ATE261301T1 (de) | 2004-03-15 |
Family
ID=25584578
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95936694T ATE261301T1 (de) | 1994-11-15 | 1995-11-14 | Arzneizubereitungen enthaltend nicht-steroidale entzündungshemmende arzneimittel |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5854226A (de) |
| EP (1) | EP0792147B1 (de) |
| JP (1) | JPH10508835A (de) |
| CN (1) | CN1171738A (de) |
| AT (1) | ATE261301T1 (de) |
| AU (1) | AU694577B2 (de) |
| DE (1) | DE69532678D1 (de) |
| WO (1) | WO1996014839A1 (de) |
| ZA (1) | ZA959469B (de) |
Families Citing this family (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1283029B1 (it) * | 1996-05-17 | 1998-04-03 | Resa Farma | Composizioni farmaceutiche a base di diclofenac |
| AU5774796A (en) * | 1995-06-13 | 1997-01-09 | Dyer, Alison Margaret | Pharmaceutical compositions containing lornoxicam and cyclod extrin |
| US6974595B1 (en) * | 1996-05-17 | 2005-12-13 | Proethic Pharmaceuticals, Inc. | Pharmaceutical compositions based on Diclofenae |
| US7687542B2 (en) | 1996-05-17 | 2010-03-30 | Kowa Pharmaeuticals America, Inc. | Rapidly bioavailable tablet and capsule formulations of diclofenac |
| FR2768339A1 (fr) * | 1997-09-18 | 1999-03-19 | Neufville Axel De | Utilisation d'un oxicam en tant qu'anti-migraineux |
| US8231899B2 (en) | 1998-09-10 | 2012-07-31 | Nycomed Danmark Aps | Quick release pharmaceutical compositions of drug substances |
| DE69905380T2 (de) | 1998-09-10 | 2003-11-27 | Nycomed Danmark A/S, Roskilde | Pharmazeutische zusammensetzungen mit schneller freisetzung von wirkstoffen |
| DE19912436A1 (de) * | 1999-03-19 | 2000-09-21 | Merckle Gmbh | Ibuprofen-Lösung |
| ES2171110B1 (es) * | 2000-03-03 | 2003-06-16 | Aplicaciones Farmacodinamicas | Composicion farmaceutica a base de ibuprofeno y procedimiento para su preparacion. |
| US7049146B2 (en) | 2000-11-14 | 2006-05-23 | Facet Analytical Services And Technology, Llc | Calibration standards, methods, and kits for water determination |
| US7122376B2 (en) * | 2001-11-01 | 2006-10-17 | Facet Analytical Services And Technology, Llc | Calibration standards, methods, and kits for water determination |
| US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
| US20050233003A1 (en) * | 2001-09-28 | 2005-10-20 | Solubest Ltd. | Hydrophilic dispersions of nanoparticles of inclusion complexes of salicylic acid |
| US20050227911A1 (en) * | 2001-09-28 | 2005-10-13 | Solubest Ltd. | Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules |
| US6878693B2 (en) | 2001-09-28 | 2005-04-12 | Solubest Ltd. | Hydrophilic complexes of lipophilic materials and an apparatus and method for their production |
| US7700851B2 (en) * | 2001-11-13 | 2010-04-20 | U.S. Smokeless Tobacco Company | Tobacco nicotine demethylase genomic clone and uses thereof |
| ITMI20012749A1 (it) * | 2001-12-21 | 2003-06-21 | Chiesi Farma Spa | Procedimento per la preparazione mediante trattamento con microonde di composti di inclusione tra farmaco e ciclodestrine e prodotti ottenut |
| US20040131504A1 (en) * | 2002-09-17 | 2004-07-08 | Landers James P. | Remote temperature sensing of small volume and related apparatus thereof |
| US8216610B2 (en) * | 2004-05-28 | 2012-07-10 | Imaginot Pty Ltd. | Oral paracetamol formulations |
| PL1916994T3 (pl) * | 2004-06-29 | 2014-05-30 | Takeda Pharma As | Wytwarzanie kompozycji farmaceutycznej o szybkim uwalnianiu leków nierozpuszczalnych w wodzie i kompozycje farmaceutyczne otrzymywane sposobem według wynalazku |
| ATE543491T1 (de) | 2004-07-07 | 2012-02-15 | Aft Pharmaceuticals Ltd | Kombinationspräparat enthaltend ibuprofen und paracetamol |
| US20060088590A1 (en) * | 2004-10-22 | 2006-04-27 | Banner Pharmacaps, Inc. | Non-blooming gelatin and non-gelatin formulations |
| AU2005319578A1 (en) * | 2004-11-24 | 2006-06-29 | Neopro Labs, Llc | Methods and compositions for treating conditions |
| JO3352B1 (ar) * | 2005-06-17 | 2019-03-13 | Apr Applied Pharma Res Sa | صيغ دايكلوفيناك وطرق استخدامه |
| CA2629904C (en) | 2005-11-28 | 2018-07-10 | Imaginot Pty Ltd. | Oral therapeutic compound delivery system |
| US7700125B2 (en) | 2006-02-07 | 2010-04-20 | Kowa Pharmaceuticals America, Inc. | Moisture resistant container systems for rapidly bioavailable dosage forms |
| US7939561B2 (en) | 2006-02-07 | 2011-05-10 | Apr Applied Pharma Research S.A. | Blister packaging for acute pain regimens |
| CN101410123A (zh) * | 2006-03-28 | 2009-04-15 | 杰佛林制药公司 | 低剂量的双氯芬酸和β－环糊精的制剂 |
| US20070232567A1 (en) * | 2006-03-28 | 2007-10-04 | Curtis Wright | Formulations Of Low Dose Non-Steroidal Anti-Inflammatory Drugs And Beta-Cyclodextrin |
| EP2015765A4 (de) * | 2006-03-28 | 2011-11-23 | Neopro Labs Llc | Verfahren und zusammensetzungen zur behandlung von erkrankungen |
| CN100560058C (zh) * | 2006-05-23 | 2009-11-18 | 姚俊华 | 一种口服、快速起效的镇痛药物 |
| US7985542B2 (en) | 2006-09-07 | 2011-07-26 | Institut Pasteur | Genomic morse code |
| EP1974751A1 (de) * | 2007-03-26 | 2008-10-01 | The Jordanian Pharmaceutical Manufacturing Co. | Formulierungen für nichtsteroidale entzündungshemmende Arzneimittel |
| WO2008144675A1 (en) | 2007-05-17 | 2008-11-27 | Neopro Labs, Llc | Crystalline and amorphous forms of peptide |
| EP2152912B1 (de) | 2007-06-07 | 2013-12-25 | Haplomic Technologies Pty Ltd | In-situ-verfahren zur genkartierung und haplotypisierung |
| US20090069237A1 (en) * | 2007-07-18 | 2009-03-12 | Hanna Skubatch | Methods and compositions for treating conditions |
| US7662858B2 (en) | 2008-05-23 | 2010-02-16 | Aaipharma, Inc. | Method of treating post-surgical acute pain |
| US9220698B2 (en) | 2008-09-09 | 2015-12-29 | Pozen Inc. | Method for delivering a pharmaceutical composition to patient in need thereof |
| US8618164B2 (en) | 2009-03-31 | 2013-12-31 | Nuvo Research Inc. | Treatment of pain with topical diclofenac compounds |
| KR20120030106A (ko) | 2009-06-25 | 2012-03-27 | 아스트라제네카 아베 | Ｎｓａｉｄ-연관된 궤양의 발생 위험이 있는 환자의 치료 방법 |
| WO2011013019A1 (en) | 2009-07-31 | 2011-02-03 | Centre Hospitalier Universitaire Vaudois | Methods for diagnosing or predicting hepatitis c outcome in hcv infected patients |
| US20110052679A1 (en) | 2009-08-25 | 2011-03-03 | Pharmaceutics International, Inc. | Solid naproxen concentrates and related dosage forms |
| GB0922377D0 (en) | 2009-12-22 | 2010-02-03 | Arab Gulf University The | Mutant LDL receptor |
| EP2394641A1 (de) | 2010-05-30 | 2011-12-14 | Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi | Pharmazeutische Formulationen von Lornoxicam |
| EP2726632A1 (de) | 2011-06-30 | 2014-05-07 | Centre Hospitaller Universitaire Vaudois (CHUV) | Polymorphismen in zusammenhang mit fehlendem ansprechen auf eine hepatitis-c-behandlung oder der anfälligkeit für nicht-spontane hepatitis-c-heilung |
| EP2797600A4 (de) | 2011-12-28 | 2015-09-16 | Pozen Inc | Verbesserte zusammensetzungen und verfahren zur abgabe von omeprazol und acetylsalicylsäure |
| AU2013215237B2 (en) * | 2012-01-30 | 2017-11-23 | Baxalta GmbH | Non-anticoagulant sulfated or sulfonated polysaccharides |
| MY191574A (en) * | 2015-02-10 | 2022-06-30 | Axsome Therapeutics Inc | Pharmaceutical compositions comprising meloxicam |
| ITUB20161016A1 (it) * | 2016-02-24 | 2017-08-24 | Emenem Srl | Composizioni farmaceutiche o cosmetiche comprendenti un polimero e un promotore di assorbimento per il rilascio controllato di principi attivi |
| CN110199031A (zh) | 2016-11-29 | 2019-09-03 | 基因组影像公司 | 设计用于分析感兴趣的遗传区域中的特定事件的一组多核苷酸序列的方法 |
| EP4467600A3 (de) * | 2017-05-10 | 2025-03-12 | Axsome Therapeutics, Inc. | Pharmazeutische zusammensetzungen mit meloxicam |
| US11197830B2 (en) | 2019-02-27 | 2021-12-14 | Aft Pharmaceuticals Limited | Pharmaceutical composition containing acetaminophen and ibuprofen |
| IL324832A (en) * | 2023-06-02 | 2026-01-01 | Ioulia Tseti | Pharmaceutical composition comprising ibuprofen |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU176215B (en) * | 1978-01-27 | 1981-01-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing a cyclodextrin-indomethacin inclusion complex with a ratio of at about 2:1 |
| JPS5920230A (ja) * | 1982-07-19 | 1984-02-01 | チバ−ガイギ−・アクチエンゲゼルシヤフト | ピルプロフエン含有薬剤 |
| IT1196033B (it) * | 1984-02-22 | 1988-11-10 | Chiesi Farma Spa | Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche |
| GB8813682D0 (en) * | 1988-06-09 | 1988-07-13 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions |
| US5206025A (en) * | 1989-05-24 | 1993-04-27 | Rhone-Poulenc Sante | Porous pharmaceutical form and its preparation |
| US5376645A (en) * | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| IT1241088B (it) * | 1990-03-27 | 1993-12-29 | Chiesi Farma Spa | Procedimento per la preparazione di complessi piroxicam/ciclodestrina,prodotti ottenuti e loro composizioni farmaceutiche |
| DE69231457T2 (de) * | 1991-06-21 | 2001-05-23 | Takeda Chemical Industries Ltd | Zyklodextrin-Zusammensetzung enthaltend Fumagillol-Derivate |
| US5472954A (en) * | 1992-07-14 | 1995-12-05 | Cyclops H.F. | Cyclodextrin complexation |
| US5362758A (en) * | 1992-09-18 | 1994-11-08 | Pfizer Inc. | Ophthalmic piroxicam solution |
| GB9316580D0 (en) * | 1993-08-10 | 1993-09-29 | Smithkline Beecham Plc | Pharmaceutical composition |
| US5646131A (en) * | 1994-02-22 | 1997-07-08 | The Arab Company For Drug Industries And Medical Applicances (Acdima) | Method for solubilizing drugs using cyclodextrins and carboxylic acids |
| EP0760680A1 (de) * | 1994-05-27 | 1997-03-12 | Farmarc Nederland Bv | Pharmazeutische zusammensetzungen |
-
1995
- 1995-11-08 ZA ZA959469A patent/ZA959469B/xx unknown
- 1995-11-14 AT AT95936694T patent/ATE261301T1/de not_active IP Right Cessation
- 1995-11-14 WO PCT/GB1995/002679 patent/WO1996014839A1/en not_active Ceased
- 1995-11-14 CN CN95197252A patent/CN1171738A/zh active Pending
- 1995-11-14 US US08/849,059 patent/US5854226A/en not_active Expired - Lifetime
- 1995-11-14 JP JP8515851A patent/JPH10508835A/ja active Pending
- 1995-11-14 AU AU38538/95A patent/AU694577B2/en not_active Ceased
- 1995-11-14 DE DE69532678T patent/DE69532678D1/de not_active Expired - Lifetime
- 1995-11-14 EP EP95936694A patent/EP0792147B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU694577B2 (en) | 1998-07-23 |
| EP0792147A1 (de) | 1997-09-03 |
| EP0792147B1 (de) | 2004-03-10 |
| CN1171738A (zh) | 1998-01-28 |
| AU3853895A (en) | 1996-06-06 |
| JPH10508835A (ja) | 1998-09-02 |
| WO1996014839A1 (en) | 1996-05-23 |
| ZA959469B (en) | 1996-05-15 |
| US5854226A (en) | 1998-12-29 |
| DE69532678D1 (de) | 2004-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69532678D1 (de) | Arzneizubereitungen enthaltend nicht-steroidale entzündungshemmende Arzneimittel | |
| DZ1884A1 (fr) | Formulations orales liquides d'alendronate. | |
| DE69521688D1 (de) | Pharmazeutische brausepräparate enthaltend bioabbaubare mikrokapseln zur kontrolierten wirkstofffreisetzung | |
| AU1079701A (en) | Oral transmucosal drug dosage using solid solution | |
| ATE280572T1 (de) | Verabreichung von arzneistoffen im unteren verdauungstrakt | |
| EP1275381A4 (de) | Feste überzogene zubereitungen mit zeitabhängiger freisetzung zur oralen verabreichung | |
| DE69519685D1 (de) | Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe | |
| ATE205705T1 (de) | Arzneimittel zum wirkstoff - targetting in den dickdarm | |
| HUP0204159A2 (hu) | Prosztaglandin-készítmények és alkalmazásuk erekciós zavarok kezelésére szolgáló gyógyszerek előállítására | |
| ATE279914T1 (de) | Oral anzuwendendes arzneimittel zur wirkstoffverabreichung im magendarmtrakt | |
| DE69306379D1 (de) | Inhalierbare arzneimittel | |
| NO306894B1 (no) | Anvendelse av galanthamin for fremstilling av en farmasöytisk formulering for behandling av nikotinavhengighet | |
| ATE213633T1 (de) | Lamotrigin haltiges arzneimittel | |
| CY1110184T1 (el) | Φαρμακευτικη συνθεση για μαλακες καψουλες για χορηγηση απο το στομα η οποια περιεχει βινορελβινη και μεθοδος θεραπειας | |
| AR035946A1 (es) | Composiciones farmaceuticas estrogenicas para usar en el tratamiento de desordenes en mujeres perimenopausicas, menopausicas o posmenopausicas, y usos de dichas composiciones para la preparacion de medicamentos | |
| CA1333773C (en) | Antitussive liquid compositions containing phenol | |
| MXPA01009297A (es) | Composiciones bioadhesivas, medicadas, topicas y metodos para su uso y preparacion. | |
| KR950031049A (ko) | 풍미된 필름 제피를 함유하는 고형의 약제학적 용량형 | |
| HK40089892A (zh) | 含有阿戈美拉汀的经粘膜治疗系统 | |
| CA2187153A1 (en) | Effervescent pharmaceutical formulations containing controlled release biodegradable microcapsules | |
| Turner | Maalox. Antacid: see ALUMINIUM | |
| BENSERAZIDE et al. | conditions: see DEXAMETHASONE | |
| TH22304A (th) | สารเตรียมทางเภสัชกรรมแบบหลายหน่วยที่มีสารยัยยั้งปั๊มโปรตอน | |
| CA2388431A1 (en) | Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |